{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:52:22Z","timestamp":1785552742683,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.autrev.2026.104055","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:21:07Z","timestamp":1775438467000},"page":"104055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis"],"prefix":"10.1016","volume":"25","author":[{"given":"Mauro","family":"Fatica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Massimo","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Conigliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104055_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","article-title":"Psoriatic arthritis: state of the art review","volume":"17","author":"Coates","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.autrev.2026.104055_bb0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/14712598.2024.2384090","article-title":"The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in psoriatic arthritis","volume":"24","author":"Caso","year":"2024","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.autrev.2026.104055_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-022-00874-5","article-title":"Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy","volume":"19","author":"Najm","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104055_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001083","article-title":"Treat-to-target in PsA: methods and necessity","volume":"6","author":"Dures","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104055_bb0025","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/14712598.2022.2152321","article-title":"What\u2019s new and what\u2019s next for biological and targeted synthetic treatments in psoriatic arthritis?","volume":"22","author":"Sunzini","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.autrev.2026.104055_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005250","article-title":"Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies","volume":"11","author":"Gladman","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104055_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard-2024-226150","article-title":"Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium","volume":"84","author":"Karmacharya","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104055_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2024.104641","article-title":"A framework for longitudinal latent factor modelling of treatment response in clinical trials with applications to psoriatic arthritis and rheumatoid arthritis","volume":"154","author":"Falck","year":"2024","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.autrev.2026.104055_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41927-024-00375-w","article-title":"Continuous improvement through differential trajectories of individual minimal disease activity criteria with Guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study","volume":"8","author":"Coates","year":"2024","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.autrev.2026.104055_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003570","article-title":"Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS)","volume":"9","author":"Pina Vegas","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104055_bb0055","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104055_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/NT.0000000000000092","article-title":"Body mass index: obesity, BMI, and health: a critical review","volume":"50","author":"Nuttall","year":"2015","journal-title":"Nutr Today"},{"issue":"Suppl. 11","key":"10.1016\/j.autrev.2026.104055_bb0065","first-page":"S64","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care Res Hoboken"},{"key":"10.1016\/j.autrev.2026.104055_bb0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104055_bb0075","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","article-title":"Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score","volume":"75","author":"Schoels","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104055_bb0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2475530320975379","article-title":"Potential differences in clinical features, disease activity, function and impact of disease between oligo and polyarticular psoriatic arthritis","volume":"6","author":"Lubrano","year":"2020","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"10.1016\/j.autrev.2026.104055_bb0085","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard-2024-225534","article-title":"Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis","volume":"83","author":"Kerschbaumer","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104055_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3899\/jrheum.170449","article-title":"Minimal disease activity as a treatment target in psoriatic arthritis: a review of the literature","volume":"45","author":"Gossec","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2026.104055_bb0095","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s40744-025-00789-z","article-title":"Characterization of super-responder profile in patients with psoriatic arthritis treated with b\/tsDMARDs: a retrospective study of a longitudinal cohort","volume":"12","author":"Perrotta","year":"2025","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2026.104055_bb0100","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1007\/s10067-024-07193-y","article-title":"Factors predicting treatment response to biological and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis - a systematic review and meta-analysis","volume":"43","author":"K\u00fcnzler","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104055_bb0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40744-020-00215-6","article-title":"Obesity and psoriatic arthritis: a narrative review","volume":"7","author":"Kumthekar","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2026.104055_bb0110","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3899\/jrheum.151491","article-title":"The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study","volume":"43","author":"Brikman","year":"2016","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104055_bb0115","article-title":"Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals","volume":"8","author":"Ribeiro","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.autrev.2026.104055_bb0120","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40744-023-00574-w","article-title":"Difficult to treat and refractory to treatment in psoriatic arthritis","volume":"10","author":"Lubrano","year":"2023","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2026.104055_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/bja\/aet127","article-title":"Sex differences in pain: a brief review of clinical and experimental findings","volume":"111","author":"Bartley","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.autrev.2026.104055_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ard.2025.10.002","article-title":"EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis","volume":"85","author":"Marzo-Ortega","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104055_bb0135","doi-asserted-by":"crossref","first-page":"418","DOI":"10.31138\/mjr.301223.dpa","article-title":"Disease profile and achievement of therapeutic goals in a modern, nationwide cohort of 923 patients with psoriatic arthritis","volume":"34","author":"Fragoulis","year":"2023","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.autrev.2026.104055_bb0140","doi-asserted-by":"crossref","DOI":"10.4081\/reumatismo.2024.1775","article-title":"Psoriasis in women with psoriatic arthritis: hormonal effects, fertility, and considerations for management at different stages of life","volume":"76","author":"Cassalia","year":"2024","journal-title":"Reumatismo"},{"issue":"3","key":"10.1016\/j.autrev.2026.104055_bb0145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40744-023-00535-3","article-title":"Psoriatic arthritis in males and females: differences and similarities","volume":"10","author":"Lubrano","year":"2023","journal-title":"Rheumatol Ther"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:16:58Z","timestamp":1777130218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226000698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1568997226000698"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104055","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104055"}}